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This article presents the rationale, design, and preliminary
findings of the North American Prodrome Longitudinal
Study (NAPLS), a collaborative, multisite investigation
into the earliest phase of psychotic illness. We describe
how 8 independently conceived research projects were inte-
grated methodologically, how diagnostic reliability was
achieved across sites on the Structured Interview for Pro-
dromal Syndromes, and how baseline and follow-up data
were aggregated for 888 at risk and comparison subjects.
Data are presented describing the demographic, academic/
work, and diagnostic characteristics of 3 relevant sub-
groups: persons at heightened clinical risk for psychosis,
help-seeking comparison subjects, and nonpsychiatric con-
trols. The NAPLS data set will be used to explore a series
of questions related to prodromal psychosis, including the
descriptive phenomenology of currently accepted diagnos-
tic criteria, conversion rates over a 30-month period, pre-
dictors of psychosis onset and functional disability, and





There has been increasing interest in the potential for early
detection and intervention during the prodromal phase of
a psychotic disorder, ie, the period of functional decline
before full-blownpsychotic symptoms first appear.1 Inter-
cedinghere,whenpsychological and interpersonal resour-
ces may be relatively intact, may offer the greatest
opportunity to redirect the illness’ negative trajectory.2,3
In the United States, research into the schizophrenia pro-
drome was spurred by the 1999 program announcement
issued by the National Institute of Mental Health
(NIMH), ‘‘PreventionandEarly Intervention inPsychotic
Disorders.’’ 7 projects subsequently funded by NIMH
between 2000 and 2003 focused on refining prodromal
diagnostic criteria, characterizing prodromal stages in
greater detail and improving the accuracy of risk predic-
tion models.
Experience with these projects revealed several chal-
lenges to conducting prospective research with at risk
individuals.4 Sample size is the principal obstacle to
achieving rapid progress in prodromal research because,
first, the annual incidence of new cases is presumed to be
low (ie, no more than 1 case per 10 000 persons per year
in the general population) and, second, these individuals
are hard to find. Annual recruitment has averaged 18 at
risk subjects per year in the single-site prodromal schizo-
phrenia research studies funded by NIMH since 2000.
Without a dramatic improvement in recruitment, we es-
timate that it will take nearly a decade for a single-site
study to accrue a sample of at risk subjects adequately
powered to test hypotheses related to psychosis onset, ill-
ness progression, short-term outcome, and discriminat-
ing true from false-positive prodromal cases.
Collaborative multisite projects represent 1 alternative
to the typical single-site, singlePrincipal Investigators (PI)
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approach to early schizophrenia research. Spreading re-
cruitment responsibilities across multiple sites will pro-
duce larger samples of at risk individuals over shorter
periods, thereby solving the sample size/time frame di-
lemma.4 Going forward, large samples of at risk subjects
will be necessary to detect the subtle neurobiological pro-
cesses that may drive progression to active illness.5 In the
short term,more robust samples are critical for addressing
fundamental questions about the psychosis prodrome, in-
cluding the validity of current diagnostic criteria, the pre-
cision of risk prediction methods, and the impact of early
treatment on the course of prodromal symptoms and
disorder.
The purpose of this article is to describe a recently
established consortium of prodromal psychosis research
centers known collectively as the North American Pro-
drome Longitudinal Study (NAPLS). Our goal is to re-
count how a collection of independently conceived
projects were integrated retrospectively, how reliability
was established on key diagnostic measures, and how de-
scriptive, clinical, and functional outcome variables were
selected and aggregated into a federated, longitudinal
database. Characteristics of the integrated database are
presented, including selected demographic and clinical
variables for 888 at risk and comparison subjects. We
then discuss how the cross-site data set will be utilized
to address a series of scientific questions about the nature
of the prodromal syndrome. Finally, we speculate on fu-
ture prospects for collaborative, large-scale research
approaches to early schizophrenia. First we describe
the current NAPLS sites, as well as the organization
and management of the research consortium.
NAPLS Sites, Organization, and Management
The 8 NAPLS research programs are presented in
Table 1. 7 of the investigations focus on characterizing
the schizophrenia prodrome and improving the accuracy
of prospective prediction of initial psychosis; Harvard
University (HU) was added to the NAPLS consortium
in order to include a sample of well-characterized genetic
high-risk subjects in the analysis of psychosis risk
factors.
Methodological similarities among the NAPLS sites
include identical procedures for identifying at risk sub-
jects (described below), inclusion of nonprodromal,
help-seeking, and normal comparison subjects, clinical
monitoring of subjects for at least 2 years following initial
evaluation, and conversion to psychosis as the principal
outcome of interest. Although clinical, behavioral, and
neuropsychological assessment methods differ across
the projects, there is considerable overlap in constructs
measured at baseline and follow-up evaluations.
Organizing the Research Consortium
Between January 2004 and July 2006, NAPLS PIs
designed themultisite collaboration with active participa-
tion fromNIMH program staff. Guidance for organizing
and managing consortium activities came from a recent
Institute of Medicine report on large-scale approaches to
biomedical research.6 Governance principles are summa-
rized in a memorandum of understanding, as are agree-
ments regarding access to the federated database and the
publication of results.
Consortium members agreed early on that 4 major
tasks had to be accomplished: (1) obtaining Institutional
Review Board (IRB) approval, (2) determining cross-site
consistency in diagnosis, (3) determining the core set of
variables, and (4) developing a common platform for
electronic data and procedures for data management.
Regarding IRB approval, each NAPLS site obtained
permission to contribute anonymous data to the con-
sortium database before data were merged. Methods for
establishing diagnostic reliability, selecting key variables
for the combined database, and recoding and combining
data are as follows.






Funding Date Project Title
ZHH Barbara Cornblatt April 27, 2000 Characterization of Prodromal Schizophrenia
UCSD Kristin Cadenhead May 7, 2000 Vulnerability Markers in Prodromal Schizophrenia
EU Elaine Walker March 19, 2002 Prediction of Psychosis in Schizotypal Adolescents
UCLA Tyrone Cannon January 16, 2003 Working Memory and Social Functioning in Schizophrenia
UNC Diana Perkins May 08, 2003 Enhancing the Prospective Prediction of Psychosis
YU Scott Woods May 08, 2003 Enhancing the Prospective Prediction of Psychosis
Thomas McGlashan
UT Jean Addington May 08, 2003 Enhancing the Prospective Prediction of Psychosis
HU Larry Seidman July 01, 2005 Schizophrenia—Psychopathology and Heterogeneity
Ming Tsuang
Note: NIMH, National Institute of Mental Health; ZHH, Zucker Hillside Hospital; UCSD, University of California San Diego; EU,
Emory University; UCLA, University California Los Angeles; UNC, University of North Carolina; YU, Yale University; UT,
University of Toronto; HU, Harvard University.




The NAPLS projects employ similar ascertainment and
longitudinal assessment methods. Specifically, each site
utilizes the Structured Interview for Prodromal Syn-
dromes (SIPS) to evaluate and monitor prodromal symp-
toms for all at risk and comparison subjects. Detailed
descriptions of SIPS symptom severity scales, prodromal
diagnostic criteria, and psychometric properties are avail-
able.7–9
To justify the pooling of data for at risk and compar-
ison subjects across research programs, it was necessary
to demonstrate that sites applied SIPS prodromal syn-
drome criteria equivalently. Data supporting cross-site
consistency in diagnostic methods come from a rater-
training program developed at Yale University that
teaches clinical researchers to identify features of the pro-
dromal syndrome with good reliability.8–10 The kappa
statistic11 is used to compare trainee agreement with
the ‘‘gold standard’’ diagnosis of presence or absence
of a prodromal syndrome.
Rater-training workshops were conducted at different
times at 7 NAPLS sites with 40 raters. Themajority of the
sites completed the workshop prior to recruiting clinical
at risk subjects (Emory University [EU], Harvard Uni-
versity [HU], University of California Los Angeles
[UCLA], University of California San Diego [UCSD],
University of North Carolina [UNC])9. 2 other sites (Uni-
versity of Toronto [UT] and Zucker Hillside Hospital
(ZHH)) had received training from the Yale group pre-
viously but completed the rater-training workshop as
part of the NAPLS project. Table 2 shows diagnostic
agreement before and after training at each site. Post-
training data within sites demonstrate that agreement
with gold standard diagnoses was in the excellent range
at each of the 7 centers. This bolsters confidence that
SIPS diagnostic criteria were applied uniformly across
NAPLS sites and justifies the decision to aggregate
data for independently acquired at risk and comparison
subjects.
Developing an Omnibus Assessment Protocol
Because the individual projects were originally designed
as independent investigations, baseline evaluation and
follow-up procedures differed among the studies. The di-
versity of variables and instruments required PIs to estab-
lish an omnibus assessment protocol for NAPLS, and
then to map already acquired data onto the new assess-
ment scheme. Eighteen variable domains were identified:
5 classes of demographic and developmental history var-
iables, 6 classes of baseline functioning variables, and 7
classes of longitudinal outcome variables (see Tables 3
and 4). PIs compared the range of assessment instruments
for all variable domains to identify commonalities in
measurement procedures, or when differences were
observed, to suggest options for harmonizing already
collected data. There were 3 levels of methodological con-
sistency within the 18 variable domains. In 6 instances,
measurement strategies were nearly identical across
NAPLS sites. Standardized scoring procedures, with ac-
ceptable methods for training and establishing interrater
reliability, were the norm for the SIPS, Structured Clin-
ical Interview for DSM, and Kiddie-Schedule for Affec-
tive Disorders and Schizophrenia (SADS) diagnostic
interviews and for the Cannon-Spoor Premorbid Adjust-
ment Scale.12–14 The highly structured nature of these
instruments minimizes the likelihood of measurement er-
ror related to site differences and increases confidence
that these data can be aggregated.
Methodological consistency was high, but not perfect,
for another 5 variable domains. Data collection was
identical in at least half of NAPLS sites for lifetime psy-
chiatric treatment, substance abuse, and current treat-
ments. For these domains, centers that differed in data
collection methods agreed to recode already collected
data onto the majority instruments. PIs performed
item-by-item comparisons between majority and minor-
ity measures in order to develop valid algorithms for
recoding data. When the wording of items or scoring
differences prohibited direct substitution of items, sites
consulted informants’ original interview responses to
complete the majority assessment instrument. Missing
data are infrequent for these variables in the combined
NAPLS data set (see Table 3), suggesting that the data
translation strategy was largely successful.
Assessment procedures differed widely for the remain-
ing variable domains.Within 5 of these categories (family
history of mental illness; stressful life events before and
after baseline; social, school, and work functioning), it
was necessary to generate newmeasures that could be ap-
plied retrospectively across sites. For family history, sites
recorded whether psychotic or nonpsychotic illnesses had
Table 2. AgreementbetweenTrainees andExpertTraineronSIPS
Diagnosis before and after a 2 Day Rater-Training Workshopa
Site
Rating





0.25 0.60 0.43 0.40 0.50 0.80 1.00 0.52
After
Training
1.00 1.00 0.86 0.80 0.83 1.00 1.00 0.90
Note: SIPS, Structured Interview for Prodromal Syndromes;
EU, Emory University; HU, Harvard University; UCLA,
University California Los Angeles; UCSD, University of
California San Diego; UNC, University of North Carolina; UT,
University of Toronto; ZHH, Zucker Hillside Hospital.
aAgreement expressed as kappa values23 < 0.40, poor; 0.40–
0.59, fair; 0.60–0.74, good; $ 0.75, excellent.
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been reported for subjects’ first- and second-degree rela-
tives. For stressful life events, the sites had used a range of
published measures.15–17 PIs compared all scales and
drew upon common elements to create a 25-itemmeasure
of life events in the areas of school/work, family disrup-
tion, personal and relationship problems, and traumatic
events or natural disasters. In addition, each site reviewed
all original documentation and consulted with relevant
clinical and research staff to determine whether events oc-
curred in childhood, early adolescence, late adolescence,
or adulthood.
Measures of social and instrumental role functioning
were particularly variable across sites and it became ap-
parent that most established measures of functioning
were not particularly suited to this population. The arti-
cle by Cornblatt and Cannon in this issue18 illustrates
how global measures of social functioning and instru-
mental role performance were developed to overcome
these limitations of existing instruments for the NAPLS
project and how raters were trained to apply these scales
to source materials.
Cognitive performance variables presented unique
challenges to the omnibus assessment protocol. A total
of 68 different neurocognitive measures derived from 40
separate testswere used in the individualNAPLSprojects,
withvaryingdegreesofoverlapobservedbetween the sites.
Decisions regardingwhich tests, or componentsof tests, to
include in the omnibus protocol weremade on the basis of
(1) representation across 4 ormore sites, (2) comparability
of test versions, administration procedures, and scoring,
and/or (3) coverage of presumed areas of separable cogni-
tive impairment in schizophrenia.19 In all, 13 cognitive
variables derived from 8 tests were selected for the
cross-site assessment battery, representing the domains
of IQ, estimated academic achievement, attention/vigi-
lance, speedof processing, workingmemory, verbal learn-
ing and memory, visual learning and memory, reasoning
and problem solving, and motor functioning.
In sum, 273 variables within 11 baseline domains and
182 variables within 7 follow-up domains are included in
the omnibus assessment protocol. Each variable is sum-
marized in the comprehensive NAPLS assessment code-
book, assuring a standardized approach to NAPLS data
recoding and aggregation. Table 3 summarizes missing
data for each baseline variable domain.
Translating Data to the Omnibus Assessment Protocol
A versatile data integration program with appropriate
safeguards for error was created by UCLA to convert
site-specific data to the omnibus format. Data recoding
and translation began in July 2005 and was completed in
February 2006 for baseline and November 2006 for
follow-up data. Site-specific data sets were combined
at UCLA for baseline data and at Toronto for follow-
up data. Appropriate cleaning and checking procedures
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baseline database was distributed to PIs in October 2006
and the follow-up data set in March 2007.
Eligible Subjects
Inclusion criteria are intentionally broad for the NAPLS
project as our goal is to maximize the number of subjects
eligible for the collaborative project. Consequently, any
subject with a valid SIPS diagnosis at initial assessment
can be admitted into the baseline database. Among these
individuals, any subject who has also completed at least 1
subsequent clinical evaluation (6, 12, 18, 24, or 30
months) is included in follow-up analyses. Beyond these
minimal requirements, there are no restrictions on
which individuals can be included in the federated
NAPLS database.
Results
A total of 888 subjects enrolled in North American pro-
dromal schizophrenia research projects between the years
1998 and 2005 are included in the baseline database.
Among this group, 651 subjects have sufficient data
for planned outcome analyses. The majority of subjects
(n = 801) had been recruited into longitudinal assessment
studies with naturalistic designs; approximately 10% (n =
87) had participated in medication trials, with random
assignment to either placebo or active treatment. For
the purpose of this article, the NAPLS sample is orga-
nized into 6 nonoverlapping groups that reflect varying
degrees of psychosis vulnerability (see Table 5). Group
assignments are made on the basis of subjects’ SIPS
responses during the initial diagnostic interview, infor-
mation about family history of psychotic disorders,
and the presence or absence of Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition (DSM-IV)
schizotypal personality disorder at the time of index
evaluation.
Individuals believed to be at heightened clinical risk for
psychosismake up the largest subgroup in the database (n =
370). These were all help-seeking individuals who pre-
sented for evaluation and treatment at established clinical
and psychiatric settings. The Criteria of Prodromal Syn-
dromes (COPS; see Table 6) describe 3 pathways to
a SIPS prodromal syndrome diagnosis: (1) presence of
attenuated positive symptoms such as perceptual abnor-
malities, suspiciousness, and unusual ideas (Attenuated
Positive Symptom Syndrome [APSS]), (2) genetic risk
for psychosis coupled with deterioration in global func-
tioning (Genetic Risk and Deterioration Syndrome
[GRDS]), and (3) intermittent psychotic symptoms
that are recent, brief in duration, and not seriously dis-
organizing or dangerous (Brief Intermittent Psychotic
Syndrome [BIPS]). Most subjects in the NAPLS clinical
high-risk (CHR) group reported APSS only (349; 94.3%).
BIPS and GRDS diagnoses were far less common (2.9
and 0.6%, respectively), and multiple prodromal diagno-
ses were equally rare (2.2%).
Other at risk groups include individuals with 1 or
more first-degree relatives who are diagnosed with any
form of psychotic illness (n = 65), persons who meet
DSM-IV criteria for schizotypal personality disorder (n =
56), and patients with recently developed psychotic
symptoms (n = 28). Additional comparison groups in-
clude help seekers who fail to meet criteria for elevated
clinical risk by COPS (n = 174) and nonpsychiatric con-
trols (NPCs) (n = 195). Because help seekers report
a plethora of worrisome clinical symptoms, they are in-
cluded to test the sensitivity and specificity of current pro-
dromal diagnostic criteria. NPC subjects provide
benchmark information regarding normal developmen-
tal processes in adolescents and young adults.
Table 7 compares subjects in the 3 largest NAPLS sub-
groups on selected demographic, instrumental function-
ing, and diagnostic variables. The CHR and help-seeking
control (HSC) samples are similar in gender and race but
differ in age and schooling. Compared with other sub-
jects, members of the HSC group are significantly youn-
ger, have completed fewer years of education, and are
more likely to be enrolled in school at the time of initial
assessment. NPCs are more diverse in terms of gender
and race and have completed more years of formal edu-
cation. The 3 groups are similar in socioeconomic back-
ground (measured by level of parental education) and
competitive employment at baseline.




























Nearly identical methods U U
Consistency across $4 sites U U
Inconsistency across sites U U U
Note: DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.
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DSM-IV psychotic disorders were not observed among
CHR, HSC, and NPC subjects. Mood and anxiety
disorders were prevalent in both clinical samples but
were absent among NPC subjects. Alcohol-related diag-
noses were equivalent in the CHR and HSC groups, but
substance abuse/dependence was somewhat more likely
among CHR subjects (v2 = 3.969, [1, 490], P < 0.05).
In general, alcohol and drug problems were rare among
NPC subjects.
Discussion
The scientific literature regarding the prodrome to psy-
chosis is expanding rapidly, with 176 of 193 peer-
reviewed articles on the topic published since 1995 (see
Figure 1). Most empirical studies from this literature re-
flect a single-site, single-investigator approach to science
that is well suited for studying high-prevalence disorders
but are less effective in CHR research, in which subjects
are more difficult to locate and recruit. A different inves-
tigative strategy may be required to accelerate scientific
progress in understanding the earliest stages of psychotic
illness. Integrated multisite research programs represent
1 alternative model for acquiring large samples of at risk
individuals and following them over time. Interest in this
approach is growing, as evidenced by both the NAPLS
project and a recent article describing the multisite Euro-
pean Prediction of Psychosis Study (EPOS).21
The present article focuses on the mechanics of estab-
lishing a viable consortium among research projects orig-
inally conceived as independent scientific investigations.
The existence of the federated NAPLS database proves
that effective cross-site collaboration is possible. Success
ultimately depended on a number of structural and pro-
cedural factors, including early administrative oversight
by NIMH program staff, a consistent schedule of contact
between PIs, action plans and timelines for completing
tasks, and a consensus building approach to decision
making. NIMH leadership served as an early catalyst
for cooperation by smoothing over preexisting differen-
ces among PIs, highlighting commonalities in research
goals and methods, and fostering teamwork. A demo-
cratic governing structure emerged during the second
year of operation and continues to the present. NAPLS
is now a self-governing enterprise, with minimal Federal
involvement in managing the project.
While a retrospectively integrated data set such as
NAPLS can provide valuable data on common and reli-
ably collected measures, there are limitations to this ap-
proach. For example, neurocognitive measures may lack
standard administration across sites, with a consequent
penalty in error variance. Other limitations include the
exclusion of subjects who meet CHR criteria but are
not help seeking, such as those identified in epidemiolog-
ical studies who report psychotic like experiences.22
Table 5. Criteria for Subjects’ Group Assignment
Study
Group N Assignment Criteria
CHR 370 Subject meets severity, onset, and duration
threshold of COPS
GHR 65 Subject does not meet criteria for CHR
Subject does not display psychotic symptoms
One or more first-degree relatives with a diagnosis
of schizophrenia, schizoaffective disorder,
schizophreniform disorder, delusional disorder,
brief psychotic disorder, psychotic disorder
not otherwise specified, major depressive
disorder with psychotic features, or bipolar
disorder with psychotic features
SPD 56 Subject does not meet criteria for CHR or GHR
Subject does not display psychotic symptoms
Subject meets DSM-IV criteria for schizotypal
personality disorder
POPS 28 Subject meets criteria for the presence of psychotic
symptoms24
HSC 174 Subject presented for help at a prodromal
psychosis research clinic
Subject does not meet criteria for CHR, GHR,
SPD, or POPS
NPC 195 Subject was recruited as a normal control subject
Subject does not meet criteria for CHR, GHR,
SPD, POPS, or HSC
Note: CHR, clinical high risk; COPS, Criteria of Prodromal
Symptoms; GHR, genetic high risk; SPD, schizotypal
personality disorder; DSM-IV, Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition; POPS, psychotic
symptoms; HSC, help-seeking controls; NPC, nonpsychiatric
controls.
Table 6. Criteria of Prodromal Syndromes9,24
1. Attenuated Positive Symptom Syndrome
1.1. Severity rating of moderate (3), moderately severe (4), or
severe but not psychotic (5) on any one of the 5 SIPS positive
symptoms
1.2. Symptom occurs at above severity level at an average
frequency of at least once per week in the past month
1.3. Symptom must have begun in the past year or currently rates
at least one scale point higher than rated 12 mo previously
2. Genetic Risk and Deterioration Syndrome
2.1. First-degree relative with psychosis or patient with
schizotypal personality disorder
2.2. 30% drop in Global Assessment of Functioning score
compared with that 1 y ago, sustained over the past month
3. Brief Intermittent Psychotic Syndrome
3.1. Severity rating of psychotic intensity (6) on any one of the 5
SIPS positive symptoms
3.2. Symptom is present at least several minutes per day at
a frequency of at least once per month
3.3. Symptom must have reached a psychotic intensity in the past
3 mo
3.4. Symptom is not seriously disorganizing or dangerous
3.5. Symptom does not last for more than 1 h/d at an average
frequency of 4 d/wk over 1 mo
Note: SIPS, Structured Interview for Prodromal Syndrome;
BIPS, Brief Intermittent Psychotic Syndrome.
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To our knowledge, the NAPLS longitudinal database
represents the largest sample of prospectively followed at
risk subjects worldwide. The database presents opportu-
nities to explore many fundamental questions related to
prodromal psychosis, including the descriptive phenom-
enology of currently accepted diagnostic criteria, conver-
sion rates over a 30-month period, predictors of psychosis
onset and functional disability, and the impact of early
treatment on the course of prodromal symptoms. Articles
on each of these topics are forthcoming. The EPOS pro-
ject21 is designed to address similar questions using com-
parable methods for ascertaining at risk subjects and
following them longitudinally. We anticipate that find-
ings from these 2 large-scale investigations will rapidly
advance our knowledge regarding the symptomatic, be-
havioral, neurocognitive, and environmental events
proximal to the onset of psychosis and taken together
and will set the direction for the next generation of pro-
dromal research studies.
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Risk, N = 370
Help-Seeking
Controls, N = 174
Nonpsychiatric
Controls, N = 195
Overall F and
v2 Values
Males (%) 61.9 64.7 45.9 v
2(2, 739) = 17.28**
Mean age (SD) 18.2 (4.7) 16.1 (3.5) 18.7 (4.5) F(2, 736) = 18.56**
Race (%) v2(4, 723) = 19.70*
White 79.8 72.1 64.4
African American 9.5 16.9 15.5
Multiracial/other 10.6 11.0 20.1
Parental education (%) NS
$ College degree 66.3 67.1 74.6
High school graduate 27.9 29.7 20.4
< High school graduate 5.7 3.2 5.0
Mean highest grade (SD) 10.3 (3.0) 8.8 (2.5) 11.3 (3.4)§ F(2, 725) = 30.96**
School/work status (%)
Current school enrollment 69.3 87.8 70.8 v
2(2, 735) = 22.30**
Current Full-time or Part-time work 21.8 13.8 15.5 NS
DSM-IV diagnosis (%)
Psychotic disordera 0 0 0 NS
Mood disorderb 34.9 20.4 0.0 v
2(2, 496) = 56.93**
Anxiety disorderc 30.4 24.8 0.0 v
2(2, 477) = 45.01**
Alcohol abuse/dependence 15.3 16.1 3.5 v
2(2, 660) = 16.93**
Drug abuse/dependence 19.5 12.2 0.6 v
2(2, 660) = 35.85**
Note: NS, not signicifcant; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.
aSchizophrenia, schizoaffective disorder, schizophreniform disorder, delusional disorder, brief psychotic disorder, psychotic disorder
not otherwise specified, major depressive disorder with psychotic features, or bipolar disorder with psychotic features.
bMajor depression, dysthymia, or bipolar disorder.
cPanic disorder, agoraphobia, social phobia, simple phobia, obsessive compulsive disorder, or generalized anxiety disorder.
*P < .001, **P < .0001 for all group comparisons; means and percentages not sharing the same subscript differ significantly from one
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Fig. 1. Number of peer-reviewed articles published on the
prodrome to psychosis, 1976–2005.
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official views of the NIMH, the National Institutes of
Health, or any other branch of the U.S. Department
of Health and Human Services.
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